Clinical outcomes | Low RDW (n = 2894) | High RDW (n = 3152) | P value |
---|---|---|---|
Primary end point | |||
 Long-term mortality, n (%) | 113 (3.9%) | 196 (6.2%) | < 0.0001 |
Secondary endpoints | |||
 Stroke, n (%) | 35 (1.2%) | 47 (1.5%) | 0.344 |
 Readmission, n (%) | 360 (12.4%) | 459 (14.6%) | 0.016 |
 MACEs, n (%) | 317 (11.0%) | 468 (14.8%) | < 0.0001 |
 MACCEs, n (%) | 351 (12.1%) | 511 (16.2%) | < 0.0001 |
 Cardiac death, n (%) | 88 (3.0%) | 163 (5.2%) | < 0.0001 |
 Stroke, n (%) | 35 (1.2%) | 47 (1.5%) | 0.344 |
 Bleeding events, n (%) | 76 (2.6%) | 99 (3.1%) | 0.233 |
 Re-stent implantation | 118 (4.1%) | 143 (4.5%) | 0.380 |
 Recurrent MI, n (%) | 79 (2.7%) | 115 (3.6%) | 0.043 |